Transforming Precision NSCLC Care: Educating and Supporting Patients on HER2- and TROP2-Targeted ADCs

Gain a deeper understanding of HER2- and TROP2-targeted antibody–drug conjugates (ADCs) in NSCLC, including biomarker testing, mechanism of action for available ADCs, latest clinical data and guideline updates, and patient education on identification and management of ADC-related adverse events. Download the slides and read a clinical commentary from 2 nurse specialists involved in the management of patients with NSCLC.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education, in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner